Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreported
2020; Springer Science+Business Media; Volume: 30; Issue: 10 Linguagem: Inglês
10.1007/s00330-020-06900-y
ISSN1432-1084
AutoresJules Grégory, Perrine Créquit, Valérie Vilgrain, Maxime Ronot, Isabelle Boutron,
Tópico(s)Liver Disease and Transplantation
Referência(s)